Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lindsay Schaack Rothstein"'
Autor:
Sophia Sheikh, Taylor Munson, Gerard Garvan, Claire Layton, Dawn Sollee, Colleen Cowdery, Alexa Peterson, Lindsay Schaack Rothstein, Morgan Henson, Hayley Gartner, Michael Ujhelyi
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 3, Pp 377-388 (2024)
Abstract Background Digoxin is a widely prescribed drug for congestive heart failure and atrial fibrillation. Digoxin has a narrow therapeutic index and toxicity can develop quite easily. Digoxin immune fab (DIF) is an effective treatment for toxicit
Externí odkaz:
https://doaj.org/article/050b76f16d954aae986196b70ebd3a5d
Autor:
Emily Anne, Kiernan, Joseph E, Carpenter, Camille A, Dunkley, Tim P, Moran, Lindsay Schaack, Rothstein, Elizabeth, Silver, Maryam, Salehi, David D, Koch, Brent W, Morgan, Brian Patrick, Murray
Publikováno v:
Clinical toxicology (Philadelphia, Pa.). 60(9)
Historically, the first step in treating cyanide (CNChart review: A single-center, retrospective case series of patients who received 5 or 10 g of hydroxocobalamin from 01/01/2011 through 04/30/2019. Data was analyzed using descriptive statistics.Cha
Autor:
Emily Anne Kiernan, Joseph E. Carpenter, Camille A. Dunkley, Tim P. Moran, Lindsay Schaack Rothstein, Elizabeth Silver, Maryam Salehi, David D. Koch, Brent W. Morgan, Brian Patrick Murray
Historically, the first step in treating cyanide (CN-) toxicity utilized antidotes to induce methemoglobinemia. This is concerning in patients who are already hypoxemic or have elevated carboxyhemoglobin. Hydroxocobalamin (OHCbl) is now the first-lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce3ed03aab9c3ef335b442c8844fb6f2
Publikováno v:
Clinical Toxicology. 57:673-674
To the editorWe read with great interest the article recently published by Anderson et. al concerning early administration of Fab antivenom (FabAV) in patients suffering from copperhead envenomatio...